Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 37 of 37 results for valproate

  1. Using NICE Quality Standards for antenatal and postnatal mental health to improve the quality of NHS services working with women during the perinatal period

    relevant to NICE QS115 detailed trust-wide audit of the use of sodium valproate in women of childbearing age was undertaken in a...

  2. Gastroparesis in adults: oral erythromycin (ESUOM13)

    Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

  3. Management of aggression, agitation and behavioural disturbances in dementia: valproate preparations (ESUOM41)

    This evidence summary has been updated and replaced by NICE guideline NG97.

  4. Suspected neurological conditions: recognition and referral (NG127)

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

  5. Research recommendations

    zonisamide. Generalised seizures: lamotrigine, levetiracetam, sodium valproate and zonisamide. CG137/1

  6. NICE board agrees to stimulate action following publication of Independent Medicines and Medical Devices Safety Review report

    NICE to reinforce the importance of collaborative working with system partners to ensure a more integrated approach to safety recommendations made in NICE guidance

  7. More than one thousand neonatal admissions could be avoided per year by following NICE guidance

    Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.